These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20176643)

  • 1. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
    Dongiovanni P; Valenti L; Rametta R; Daly AK; Nobili V; Mozzi E; Leathart JB; Pietrobattista A; Burt AD; Maggioni M; Fracanzani AL; Lattuada E; Zappa MA; Roviaro G; Marchesini G; Day CP; Fargion S
    Gut; 2010 Feb; 59(2):267-73. PubMed ID: 20176643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population.
    Baba T; Endo T; Sata F; Honnma H; Kitajima Y; Hayashi T; Manase K; Kanaya M; Yamada H; Minakami H; Kishi R; Saito T
    Life Sci; 2007 Aug; 81(10):850-4. PubMed ID: 17719609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
    González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
    Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ; Zhang L; Liu T; Hua YQ; Zheng PY; Ji G
    Eur J Pharmacol; 2011 Oct; 668(3):467-71. PubMed ID: 21839075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in non-alcoholic fatty liver disease: interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis.
    Carulli L; Canedi I; Rondinella S; Lombardini S; Ganazzi D; Fargion S; De Palma M; Lonardo A; Ricchi M; Bertolotti M; Carulli N; Loria P
    Dig Liver Dis; 2009 Nov; 41(11):823-8. PubMed ID: 19403348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENPP1 gene, insulin resistance and related clinical outcomes.
    Bacci S; De Cosmo S; Prudente S; Trischitta V
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene.
    Wan C; Zhang T; Wang B; Han Y; Zhang C; Zhang Y; Gong H; Jin F; Wang L
    Diabetes Obes Metab; 2006 Nov; 8(6):703-8. PubMed ID: 17026496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
    Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G
    Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
    Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals.
    Bochenski J; Placha G; Wanic K; Malecki M; Sieradzki J; Warram JH; Krolewski AS
    Diabetes; 2006 Sep; 55(9):2626-30. PubMed ID: 16936213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
    Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
    Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
    Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.
    Valenti L; Pulixi E; Fracanzani AL; Dongiovanni P; Maggioni M; Orsatti A; Gianni C; Fargion S
    J Hepatol; 2005 Dec; 43(6):944-50. PubMed ID: 16143422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
    Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.